CanSino Biologics Inc. (6185.HK) HKSE
33.04
-0.78(-2.31%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
33.04
-0.78(-2.31%)
Currency In HKD
| Market Cap | 7.95B |
| Enterprise Value | 7.95B |
| P/E Ratio | 700.82 |
| PEG Ratio | 5.57 |
| Price/Sales Ratio | 11.46 |
| Price/Book Ratio | 3.96 |
| Enterprise/Revenue | 11.46 |
| Enterprise/EBITDA | 59.06 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0.03 |
| Operating Margin | 0.02 |
| Return On Assets | 0 |
| Return On Equity | 0.01 |
| Revenue | 1.04B |
| Revenue/Share | 3.66 |
| Gross Profit | 0 |
| EBITDA | 23.29M |
| Net Income | 27.15M |
| Diluted EPS | 0.11 |
| Total Cash | 2.47B |
| Total Cash/Share | 0 |
| Total Debt | 1.43B |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 16.91 |
| 52-Week Change | -1.81 |
| 52-Week High | 56.55 |
| 52-Week Low | 25.25 |
| Moving Average 50 Days | 33.88 |
| Moving Average 200 Days | 40.84 |
| Average Volume | 973,520 |
| Shares Outstanding | 350.09M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 1.31 |
| Last Split Factor | N/A |
| Last Split Date | N/A |